Your browser doesn't support javascript.
loading
Knockdown of NAT12/NAA30 reduces tumorigenic features of glioblastoma-initiating cells.
Mughal, Awais A; Grieg, Zanina; Skjellegrind, Håvard; Fayzullin, Artem; Lamkhannat, Mustapha; Joel, Mrinal; Ahmed, M Shakil; Murrell, Wayne; Vik-Mo, Einar O; Langmoen, Iver A; Stangeland, Biljana.
Afiliación
  • Mughal AA; Vilhelm Magnus Laboratory for Neurosurgical Research, Institute for Surgical Research and Department of Neurosurgery, Oslo University Hospital, Oslo, Norway. awaisam@gmail.com.
  • Grieg Z; SFI-CAST-Cancer Stem Cell Innovation Center, Oslo University Hospital, Oslo, Norway. awaisam@gmail.com.
  • Skjellegrind H; Vilhelm Magnus Laboratory for Neurosurgical Research, Institute for Surgical Research and Department of Neurosurgery, Oslo University Hospital, Oslo, Norway. zanina_grieg@yahoo.no.
  • Fayzullin A; Norwegian Center for Stem Cell Research, Department of Immunology and Transfusion Medicine, Oslo University Hospital, Oslo, Norway. zanina_grieg@yahoo.no.
  • Lamkhannat M; Vilhelm Magnus Laboratory for Neurosurgical Research, Institute for Surgical Research and Department of Neurosurgery, Oslo University Hospital, Oslo, Norway. havard@skjellegrind.no.
  • Joel M; Vilhelm Magnus Laboratory for Neurosurgical Research, Institute for Surgical Research and Department of Neurosurgery, Oslo University Hospital, Oslo, Norway. artem.fayzullin@rr-research.no.
  • Ahmed MS; Vilhelm Magnus Laboratory for Neurosurgical Research, Institute for Surgical Research and Department of Neurosurgery, Oslo University Hospital, Oslo, Norway. lamkhannat@gmail.com.
  • Murrell W; Vilhelm Magnus Laboratory for Neurosurgical Research, Institute for Surgical Research and Department of Neurosurgery, Oslo University Hospital, Oslo, Norway. mrinaj@medisin.uio.no.
  • Vik-Mo EO; Norwegian Center for Stem Cell Research, Department of Immunology and Transfusion Medicine, Oslo University Hospital, Oslo, Norway. mrinaj@medisin.uio.no.
  • Langmoen IA; Laboratory of Neural Development and Optical Recording (NDEVOR), Department of Physiology, Institute of Basic Medical Sciences University of Oslo, Oslo, Norway. mrinaj@medisin.uio.no.
  • Stangeland B; Institute for Surgical Research, Oslo University Hospital and Center for Heart Failure Research, University of Oslo, Oslo, Norway. Muhammad.Shakil.Ahmed@rr-research.no.
Mol Cancer ; 14: 160, 2015 Aug 21.
Article en En | MEDLINE | ID: mdl-26292663
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteína p53 Supresora de Tumor / Glioblastoma / Subunidad alfa del Factor 1 Inducible por Hipoxia / Serina-Treonina Quinasas TOR / Acetiltransferasa C N-Terminal / Proteínas de Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans / Male Idioma: En Revista: Mol Cancer Asunto de la revista: NEOPLASIAS Año: 2015 Tipo del documento: Article País de afiliación: Noruega Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteína p53 Supresora de Tumor / Glioblastoma / Subunidad alfa del Factor 1 Inducible por Hipoxia / Serina-Treonina Quinasas TOR / Acetiltransferasa C N-Terminal / Proteínas de Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans / Male Idioma: En Revista: Mol Cancer Asunto de la revista: NEOPLASIAS Año: 2015 Tipo del documento: Article País de afiliación: Noruega Pais de publicación: Reino Unido